For: | Cidon EU, Martinez PA, Hickish T. Gemcitabine-induced haemolytic uremic syndrome, although infrequent, can it be prevented: A case report and review of literature. World J Clin Cases 2018; 6(12): 531-537 [PMID: 30397609 DOI: 10.12998/wjcc.v6.i12.531] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v6/i12/531.htm |
Number | Citing Articles |
1 |
Fuxu Yang, Mingyue Wang, Xingang Guan. Exosomes and mimics as novel delivery platform for cancer therapy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1001417
|
2 |
Adarsh Das, Andrew Dean, Tim Clay. Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma. BMJ Case Reports 2019; 12(4): e228363 doi: 10.1136/bcr-2018-228363
|
3 |
Purva Sharma, Nupur N. Uppal, Rimda Wanchoo, Hitesh H. Shah, Yihe Yang, Rushang Parikh, Yuriy Khanin, Varun Madireddy, Christopher P. Larsen, Kenar D. Jhaveri, Vanesa Bijol. COVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. Journal of the American Society of Nephrology 2020; 31(9): 1948 doi: 10.1681/ASN.2020050699
|